Grant: Discovery Grants Program - Individual
Acadia University
$24,850.00
Design and study of artificial nucleases for DNA photocleavage
EF 2009-10
Résumé
Artificial nucleases are molecules capable of inducing single- or double-strand breaks in the DNA backbone. Molecules that cleave DNA upon activation with light are especially important in photodynamic therapy (PDT), a strategy that has been applied to the successful treatment of certain cancers and age-related macular degeneration. Current clinical agents for PDT suffer from three major limitations: (i) requirement for oxygen to function, (ii) minimum absorption of light at wavelengths most transparent to tissue, and (iii) inability to produce double-strand breaks. This proposal outlines a research plan that is devoted to overcoming such limitations by introducing new agents that elicit double-strand breaks in DNA under hypoxic conditions when activated with 700-900 nm light. The first proposed family of DNA photocleavers is based on dinuclear Ru(II) complexes that absorb light >700 nm. Extension of this family will include incorporation of Rh(II) to make hybrid multimetallic systems that cleave DNA in the absence of oxygen. The multimetallic framework will provide two sites of reactivity for DNA cleavage. Dual reactivity within 15-16 base pairs will introduce double-strand breaks which are more difficult for the cellular machinery to repair.
A related research stream involves the jadomycins, a family of secondary metabolites that induces DNA strand scissions in the presence of Cu(II) or with light activation. While they fall short of the properties outlined for the ideal PDT agent, jadomycins exhibit cytotoxic activity against both Gram positive and Gram negative bacteria as well as some drug-resistant cancer cell lines. This research program will determine whether direct DNA cleavage contributes to the overall cytotoxicity of the jadomycins at intracellular Cu(II) concentrations. In addition, the DNA photocleaving properties of the jadomycins will be investigated, with particular attention on the mechanism that predominates with Cu(II) activation versus light activation. The role that L-digitoxose, a structural feature of jadomycin B, plays in DNA cleavage will also be probed to better understand how glycone incorporation aids in DNA recognition.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
341612-2007
Name nom
McFarland, Sherri
Department département
Chemistry
Organization id
78
Institution établissement
Acadia University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2007
Award amount
24850
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3603
Research subject group en
Inorganic chemistry
Research subject group fr
Chimie inorganique
Research subject en
Bio-inorganic chemistry
Research subject fr
Chimie bio-inorganique
Partie
3
Nb partie
3
Application title
Design and study of artificial nucleases for DNA photocleavage
Keyword
NA
Application summary
Artificial nucleases are molecules capable of inducing single- or double-strand breaks in the DNA backbone. Molecules that cleave DNA upon activation with light are especially important in photodynamic therapy (PDT), a strategy that has been applied to the successful treatment of certain cancers and age-related macular degeneration. Current clinical agents for PDT suffer from three major limitations: (i) requirement for oxygen to function, (ii) minimum absorption of light at wavelengths most transparent to tissue, and (iii) inability to produce double-strand breaks. This proposal outlines a research plan that is devoted to overcoming such limitations by introducing new agents that elicit double-strand breaks in DNA under hypoxic conditions when activated with 700-900 nm light. The first proposed family of DNA photocleavers is based on dinuclear Ru(II) complexes that absorb light >700 nm. Extension of this family will include incorporation of Rh(II) to make hybrid multimetallic systems that cleave DNA in the absence of oxygen. The multimetallic framework will provide two sites of reactivity for DNA cleavage. Dual reactivity within 15-16 base pairs will introduce double-strand breaks which are more difficult for the cellular machinery to repair.
A related research stream involves the jadomycins, a family of secondary metabolites that induces DNA strand scissions in the presence of Cu(II) or with light activation. While they fall short of the properties outlined for the ideal PDT agent, jadomycins exhibit cytotoxic activity against both Gram positive and Gram negative bacteria as well as some drug-resistant cancer cell lines. This research program will determine whether direct DNA cleavage contributes to the overall cytotoxicity of the jadomycins at intracellular Cu(II) concentrations. In addition, the DNA photocleaving properties of the jadomycins will be investigated, with particular attention on the mechanism that predominates with Cu(II) activation versus light activation. The role that L-digitoxose, a structural feature of jadomycin B, plays in DNA cleavage will also be probed to better understand how glycone incorporation aids in DNA recognition.